Mixed
Obesity is associated with elevated circulating succinate levels, which are determined by a specific gut microbiota signature characterized by a higher ratio of succinate-producing bacteria (Prevotellaceae, Veillonellaceae) to succinate-consuming bacteria (Odoribacteraceae, Clostridaceae).
High circulating succinate, linked to obesity and cardiovascular risk, is driven by an imbalance in gut bacteria (too many producers, too few consumers). Weight loss interventions, particularly those involving a Mediterranean diet, can restore this balance by reducing succinate-producing bacteria and increasing succinate-consuming ones, thereby lowering circulating succinate levels.
Obesity was associated with elevated levels of circulating succinate concomitant with impaired glucose metabolism. This increase was associated with specific changes in gut microbiota related to succinate metabolism: a higher relative abundance of succinate-producing Prevotellaceae (P) and Veillonellaceae (V), and a lower relative abundance of succinate-consuming Odoribacteraceae (O) and Clostridaceae (C) in obese individuals, with the (P + V/O + C) ratio being a main determinant of plasma succinate.
Why this rating
The study uses multiple cohorts (cross-sectional, intervention, follow-up) and validates findings with multiple methods (fluorimetric, LC-MS/MS, NMR), though it is observational/correlational in nature for the primary association.
Source
Elevated circulating levels of succinate in human obesity are linked to specific gut microbiota
Carolina Serena et al. · The ISME Journal · 2018
DOI 10.1038/s41396-018-0068-2
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →